PACBODY
Live / Registered — Registered (as of 13 Jun 2023)
What this means for you
Registered since 13 Jun 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88658020
- Registration number
- 7080972
- Mark type
- Stylized text
- Filed
- 17 Oct 2019
- Published for opposition
- 09 Jun 2020
- Registered
- 13 Jun 2023
- Attorney of record
- Matthew R. Grothouse
Goods and services
- Class 042 — Scientific and technological services: Scientific and technological services and research and development activities relating thereto, namely, antibody research and design; Providing recombinant antibody technology platform in the nature of research and development of monospecific, bispecific and multi-specific antibodies or fragments and the development of pharmaceutical products based on monospecific, bispecific and multi-specific antibodies or fragments; Research and development services in the field of antibodies; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; medical and scientific research in the field of cancer treatment and diagnosis; technical research in the field of pharmaceutical studies; research on the subject of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; pharmaceutical product development; product developability testing, namely, pharmaceutical antibody evaluation; development of pharmaceutical preparations and medicines; product design-based functionality testing, namely, conducting early evaluations in the field of new pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; chemical, biochemical, biological and bacteriological research and analysis; biological research; scientific study, research and development in the fields of medicine, the prevention, treatment and management of illness, health care delivery; technology research in the field of pharmaceutical research and development; medical research; medical laboratories
Owner
- Phanes Therapeutics, Inc., San Diego, CA, US
- Phanes Therapeutics, Inc., San Diego, CA, US
- Phanes Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 13 Jun 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Jun 2023 — REGISTERED-PRINCIPAL REGISTER
- 11 May 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 May 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Apr 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Mar 2023 — USE AMENDMENT FILED
- 06 Apr 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Mar 2023 — TEAS STATEMENT OF USE RECEIVED
- 26 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Aug 2022 — SOU EXTENSION 4 GRANTED
- 24 Aug 2022 — SOU EXTENSION 4 FILED
- 24 Aug 2022 — SOU TEAS EXTENSION RECEIVED
- 30 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Mar 2022 — SOU EXTENSION 3 GRANTED
- 28 Mar 2022 — SOU EXTENSION 3 FILED